John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $223M | 0.67% |
823,690
+351,357
| +74% | +$94.9M |
|
2
Coca-Cola
KO
$392B
| $192M | 0.57% |
4,371,499
+1,799,784
| +70% | +$77.7M |
|
3
Comcast
CMCSA
$95.3B
| $190M | 0.57% |
5,796,365
+1,056,656
| +22% | +$34.4M |
|
4
Netflix
NFLX
$331B
| $185M | 0.55% |
4,732,980
-1,768,040
| -27% | -$60.3M |
|
5
Citigroup
C
$221B
| $184M | 0.55% |
2,755,298
+628,300
| +30% | +$43.3M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $183M | 0.55% |
2,310,066
+564,435
| +32% | +$46.9M |
|
|
7
Alphabet (Google) Class A
GOOGL
$4.22T
| $182M | 0.54% |
+3,215,020
| New | +$175M |
|
8
Honeywell
HON
$68.4B
| $176M | 0.52% |
1,351,394
+559,103
| +71% | +$74.4M |
|
|
9
Meta Platforms (Facebook)
META
$1.4T
| $175M | 0.52% |
+902,095
| New | +$163M |
|
10
IBM
IBM
$222B
| $174M | 0.52% |
1,303,870
+719,064
| +123% | +$100M |
|
|
ABMD
11
DELISTED
Abiomed Inc
ABMD
| $169M | 0.5% |
413,409
+380,507
| +1,156% | +$138M |
|
12
Home Depot
HD
$335B
| $167M | 0.5% |
858,209
+668,748
| +353% | +$125M |
|
13
Macy's
M
$6B
| $167M | 0.5% |
4,462,746
+2,965,214
| +198% | +$99.4M |
|
14
Regeneron Pharmaceuticals
REGN
$85.9B
| $167M | 0.5% |
483,334
+27,415
| +6% | +$8.57M |
|
15
lululemon athletica
LULU
$13.7B
| $167M | 0.5% |
1,335,514
-302,585
| -18% | -$32.3M |
|
16
Target
TGT
$75.1B
| $166M | 0.5% |
2,183,289
-396,414
| -15% | -$29.2M |
|
|
17
Johnson & Johnson
JNJ
$651B
| $164M | 0.49% |
1,352,873
+1,059,615
| +361% | +$132M |
|
18
Union Pacific
UNP
$183B
| $163M | 0.49% |
1,152,189
+929,446
| +417% | +$130M |
|
19
Burlington
BURL
$20.6B
| $161M | 0.48% |
1,070,833
+27,572
| +3% | +$3.92M |
|
20
Palo Alto Networks
PANW
$292B
| $158M | 0.47% |
4,607,370
-838,116
| -15% | -$27.9M |
|
21
Occidental Petroleum
OXY
$61.3B
| $156M | 0.47% |
1,864,264
+985,444
| +112% | +$78.7M |
|
22
Automatic Data Processing
ADP
$112B
| $152M | 0.45% |
1,131,835
+998,899
| +751% | +$127M |
|
23
Colgate-Palmolive
CL
$72.6B
| $150M | 0.45% |
2,321,313
+163,830
| +8% | +$10.7M |
|
24
Chevron
CVX
$403B
| $150M | 0.45% |
1,187,561
-184,129
| -13% | -$22.9M |
|
|
25
Constellation Brands
STZ
$23.2B
| $145M | 0.43% |
664,307
+597,465
| +894% | +$135M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.